Merit Medical Systems Names Sheri Lewis Executive Vice President of Global Operations

Merit Medical Systems appoints Sheri Lewis as Executive VP of Global Operations, effective August 31, 2026.

Quiver AI Summary

Merit Medical Systems, Inc. has announced the appointment of Sheri Lewis as Executive Vice President of Global Operations, effective August 31, 2026. Lewis brings 30 years of experience in global operations, manufacturing, and supply chain management from her tenure at companies like SkinHealth Systems, Avantor, Medtronic, and Honeywell. Merit CEO Martha G. Aronson highlighted Lewis's track record in leading complex organizations and improving operational efficiency, which will be crucial for Merit's global growth strategy. Current COO Neil Peterson will transition to a Senior Advisor role until March 5, 2027, after serving the company for over 32 years, contributing significantly to operational improvements and employee well-being. Merit Medical, founded in 1987, specializes in medical devices for various procedures and employs around 7,500 people globally.

Potential Positives

Merit Medical Systems has appointed Sheri Lewis as Executive Vice President of Global Operations, bringing her extensive experience from multiple leading companies in healthcare technology.
The appointment of Lewis is aimed at strengthening global operational excellence, product availability, and integrated business processes, aligning with Merit's long-term growth strategy.
Continuity is ensured with Mr. Peterson transitioning to a Senior Advisor role after over 32 years with the company, which should aid in a smooth leadership transition.
The press release highlights a commitment to operational discipline and employee well-being, fostering a positive corporate culture during leadership changes.

Potential Negatives

The transition from a long-serving Chief Operating Officer to a new Executive Vice President of Global Operations may indicate potential instability in leadership and operational continuity during a critical time for the company.
The departure of Mr. Peterson after 32 years raises concerns about the loss of deep institutional knowledge and experience that could impact operational efficiency and company culture.

FAQ

Who is the new Executive VP of Global Operations at Merit Medical?

Sheri Lewis has been appointed as the Executive Vice President of Global Operations, effective August 31, 2026.

What experience does Sheri Lewis bring to Merit Medical?

Sheri Lewis has three decades of experience in global operations, manufacturing, and supply chain management from leading companies like Medtronic and Honeywell.

What role will Neil Peterson have after his transition?

Neil Peterson will become a Senior Advisor at Merit Medical, assisting in the transition until March 5, 2027.

What are Merit's primary business activities?

Merit Medical develops, manufactures, and distributes proprietary medical devices for interventional, diagnostic, and therapeutic procedures.

How many employees does Merit Medical have globally?

Merit Medical employs approximately 7,500 people worldwide across its operations and support teams.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

EARLY ACCESS

Receive MMSI Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$MMSI Insider Trading Activity

$MMSI insiders have traded $MMSI stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MMSI stock by insiders over the last 6 months:

NEIL W. PETERSON (CHIEF OPERATING OFFICER) sold 21,449 shares for an estimated $1,823,165
CHRISTIAN ADAM SMITH (Chief Commercial Officer) purchased 1,626 shares for an estimated $99,186

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$MMSI Revenue

$MMSI had revenues of $418.8M in Q2 2026. This is an increase of 9.51% from the same period in the prior year.

You can track MMSI financials on Quiver Quantitative's MMSI stock page.

You can access data on MMSI stock through the Quiver Quantitative API.

$MMSI Hedge Fund Activity

We have seen 249 institutional investors add shares of $MMSI stock to their portfolio, and 213 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NEUBERGER BERMAN GROUP LLC added 996,617 shares (+17953.8%) to their portfolio in Q2 2026, for an estimated $69,105,422
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 743,937 shares (+inf%) to their portfolio in Q2 2026, for an estimated $51,584,591
JPMORGAN CHASE & CO added 644,037 shares (+inf%) to their portfolio in Q2 2026, for an estimated $44,657,525
BLACKROCK, INC. added 630,227 shares (+7.1%) to their portfolio in Q2 2026, for an estimated $43,699,940
IRENIC CAPITAL MANAGEMENT LP added 542,589 shares (+inf%) to their portfolio in Q2 2026, for an estimated $37,623,121
POINT72 ASSET MANAGEMENT, L.P. removed 538,203 shares (-72.5%) from their portfolio in Q2 2026, for an estimated $37,318,996
FULLER & THALER ASSET MANAGEMENT, INC. removed 502,524 shares (-23.8%) from their portfolio in Q2 2026, for an estimated $34,845,014

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$MMSI Analyst Ratings

Wall Street analysts have issued reports on $MMSI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 05/01/2026

To track analyst ratings and price targets for $MMSI, check out Quiver Quantitative's $MMSI forecast page.

$MMSI Price Targets

Multiple analysts have issued price targets for $MMSI recently. We have seen 6 analysts offer price targets for $MMSI in the last 6 months, with a median target of $87.5.

Here are some recent targets:

Mike Matson from Needham set a target price of $90.0 on 05/01/2026
Larry Biegelsen from Wells Fargo set a target price of $74.0 on 05/01/2026
Robbie Marcus from JP Morgan set a target price of $77.0 on 05/01/2026
Jon Young from Canaccord Genuity set a target price of $85.0 on 05/01/2026
Michael Petusky from Barrington Research set a target price of $107.0 on 04/20/2026
Jason Bednar from Piper Sandler set a target price of $96.0 on 04/17/2026

Full Release

SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to join Merit as Executive Vice President of Global Operations, effective August 31, 2026.

Ms. Lewis brings three decades of experience across global operations, manufacturing, and supply chain management. She previously held senior roles at SkinHealth Systems, Inc., Avantor, Medtronic, and Honeywell, leading global manufacturing, distribution, logistics, supply chain, quality, regulatory, environmental health and safety, and operational excellence functions across large, complex organizations.

"Sheri is an accomplished operations executive with a strong record of leading complex organizations and building high-performing teams," said Martha G. Aronson, Merit’s President and Chief Executive Officer. "Her experience strengthening integrated business processes, ensuring product availability, and driving global operational excellence will be important as Merit continues to scale globally and execute its long-term growth strategy."

To support continuity, Mr. Peterson will move into the role of Senior Advisor, where he will help ensure a smooth transition through March 5, 2027. At that time, Mr. Peterson will complete his service to Merit after more than 32 years with the company.

Mr. Peterson has held leadership roles across Merit’s operations and engineering functions, most recently serving as Chief Operating Officer for the past four years. Throughout his career, he has strengthened product quality, improved on-time delivery, advanced operational efficiencies, and driven cost reductions. He also helped navigate supply chain constraints, raw material shortages, and the operational challenges of the COVID-19 pandemic. Mr. Peterson has consistently shown a deep commitment to supporting employees and their well-being.

"Neil has been a dedicated and respected leader at Merit. His operational discipline, commitment to execution, and deep knowledge of our manufacturing and supply chain network have contributed meaningfully to the company’s growth and performance," added Aronson. "We are grateful for his many contributions and for the important role he has played in strengthening our global operations."

ABOUT MERIT MEDICAL

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,500 people worldwide.

CONTACTS

PR/Media Inquiries
Sarah Comstock

Merit Medical
+1-801-432-2864 | [email protected]

Investor Inquiries
Mike Piccinino, CFA, IRC
ICR Healthcare
+1-443-213-0509 | [email protected]